IE80555B1 - A process for the preparation of alkylphosphocholines and the production thereof in pure form - Google Patents
A process for the preparation of alkylphosphocholines and the production thereof in pure formInfo
- Publication number
- IE80555B1 IE80555B1 IE922182A IE922182A IE80555B1 IE 80555 B1 IE80555 B1 IE 80555B1 IE 922182 A IE922182 A IE 922182A IE 922182 A IE922182 A IE 922182A IE 80555 B1 IE80555 B1 IE 80555B1
- Authority
- IE
- Ireland
- Prior art keywords
- alkylphosphocholines
- ion exchanger
- reaction
- production
- choline salt
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 238000004519 manufacturing process Methods 0.000 title claims description 5
- 238000006243 chemical reaction Methods 0.000 claims abstract description 24
- 239000000126 substance Substances 0.000 claims abstract description 24
- 150000002500 ions Chemical class 0.000 claims abstract description 22
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 claims abstract description 22
- 239000002904 solvent Substances 0.000 claims abstract description 17
- 239000004381 Choline salt Substances 0.000 claims abstract description 12
- 235000019417 choline salt Nutrition 0.000 claims abstract description 12
- 150000003248 quinolines Chemical class 0.000 claims abstract description 11
- 230000007062 hydrolysis Effects 0.000 claims abstract description 8
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract description 8
- 238000000746 purification Methods 0.000 claims abstract description 6
- 239000012442 inert solvent Substances 0.000 claims abstract description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims abstract 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims abstract 2
- 230000002378 acidificating effect Effects 0.000 claims abstract 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims abstract 2
- 150000005690 diesters Chemical class 0.000 claims abstract 2
- 238000002955 isolation Methods 0.000 claims abstract 2
- 239000000047 product Substances 0.000 claims description 13
- 229910052799 carbon Inorganic materials 0.000 claims description 8
- 239000012043 crude product Substances 0.000 claims 1
- 239000007795 chemical reaction product Substances 0.000 abstract description 2
- 238000005580 one pot reaction Methods 0.000 abstract 1
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 18
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- 125000004432 carbon atom Chemical group C* 0.000 description 17
- 239000000203 mixture Substances 0.000 description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- 239000002253 acid Substances 0.000 description 12
- 150000001298 alcohols Chemical class 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- -1 octyl- Chemical group 0.000 description 10
- 229910052739 hydrogen Inorganic materials 0.000 description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 7
- 229910052757 nitrogen Inorganic materials 0.000 description 7
- 229920006395 saturated elastomer Polymers 0.000 description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical group CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- 150000008282 halocarbons Chemical class 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 4
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 4
- 229940052303 ethers for general anesthesia Drugs 0.000 description 4
- 235000011167 hydrochloric acid Nutrition 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 229930195734 saturated hydrocarbon Natural products 0.000 description 4
- DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 4
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 4
- 238000005160 1H NMR spectroscopy Methods 0.000 description 3
- 101150041968 CDC13 gene Proteins 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 3
- 229960000583 acetic acid Drugs 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 150000004292 cyclic ethers Chemical class 0.000 description 3
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 3
- 229930195733 hydrocarbon Natural products 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- 150000002576 ketones Chemical class 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 2
- SZNYYWIUQFZLLT-UHFFFAOYSA-N 2-methyl-1-(2-methylpropoxy)propane Chemical compound CC(C)COCC(C)C SZNYYWIUQFZLLT-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 150000001342 alkaline earth metals Chemical class 0.000 description 2
- 230000002152 alkylating effect Effects 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 2
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 125000001309 chloro group Chemical group Cl* 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical class C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 229960001231 choline Drugs 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 229940093915 gynecological organic acid Drugs 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000013067 intermediate product Substances 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- PQLXHQMOHUQAKB-UHFFFAOYSA-N miltefosine Chemical compound CCCCCCCCCCCCCCCCOP([O-])(=O)OCC[N+](C)(C)C PQLXHQMOHUQAKB-UHFFFAOYSA-N 0.000 description 2
- 229960003775 miltefosine Drugs 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 150000003014 phosphoric acid esters Chemical class 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- BDHFUVZGWQCTTF-UHFFFAOYSA-N sulfonic acid Chemical group OS(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-N 0.000 description 2
- 239000001117 sulphuric acid Substances 0.000 description 2
- 235000011149 sulphuric acid Nutrition 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- FZRJLBJACDITKM-UHFFFAOYSA-N 1,3,2-dioxaphospholane Chemical compound C1COPO1 FZRJLBJACDITKM-UHFFFAOYSA-N 0.000 description 1
- OCJBOOLMMGQPQU-UHFFFAOYSA-N 1,4-dichlorobenzene Chemical compound ClC1=CC=C(Cl)C=C1 OCJBOOLMMGQPQU-UHFFFAOYSA-N 0.000 description 1
- PYTMBSDYMPHFOQ-UHFFFAOYSA-N 2,2,2-trichloro-n-[4-(trifluoromethyl)phenyl]acetamide Chemical compound FC(F)(F)C1=CC=C(NC(=O)C(Cl)(Cl)Cl)C=C1 PYTMBSDYMPHFOQ-UHFFFAOYSA-N 0.000 description 1
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000004996 alkyl benzenes Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000004982 aromatic amines Chemical class 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 238000011210 chromatographic step Methods 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 229940117389 dichlorobenzene Drugs 0.000 description 1
- 229960004132 diethyl ether Drugs 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 150000002367 halogens Chemical group 0.000 description 1
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Steroid Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
Abstract
Process for the preparation of C14-C18-alkylphosphocholines in a one-pot process by reaction of an n-alkanol having a chain length of C14-C18 with phosphorus oxychloride in an inert solvent or else without solvent in the presence or absence of a basic substance, and further reaction of the reaction product in an inert solvent with a choline salt in the presence of a basic substance to give the phosphoric acid diester chloride, followed by hydrolysis and isolation of alkylphosphocholine, and, if appropriate, purification by means of a mixed-bed ion exchanger or in succession with an acidic ion exchanger and a basic ion exchanger.
Description
A process for the preparation of alkylphosphocholines and the production thereof in pure form Eibl et al. (EP 225,608) describe the preparation and use of alkylphosphocholines for the treatment of tumours.
The starting substances used in the Eibl process of preparation are the n-alcohol and phosphorus oxychloride. They are reacted to phosphoric acid ester dichloride in tetrahydrofuran.
In a second step 2-aminoethanol is reacted with the phosphoric acid ester dichloride to 2-hexadecyl-l,3,2-oxaphospholan-2oxide in dioxan. Hydrolysis with 2N hydrochloric acid yields the open-chain amine which is exhaustively methylated to alkylphosphocholine with dimethyl sulphate in 2-propanol.
This process has the following disadvantages: it is necessary to isolate and purify the intermediate products. In addition, alkylating reagents are used. The use of potassium carbonate as an auxiliary base in this step of the process leads to the product having a potassium content that is undesirably high for pharmaceutical purposes.
Long-chain alkylphosphocholines having an antimicrobial effect are described by Kanetani et al., Nippon Kayaku Kaushi, 9., 1452 (1984) .
They are prepared using the following process: ethylene glycol and phosphorus trichloride are reacted to form 2-chloro-l,3,2-dioxaphospholane, the product purified by distillation is oxidized with oxygen to 2-chloro-l,3,2-dioxaphospholane-2-oxide and then distilled again. The 2-chloro-l,3,2-dioxaphospholane-2-oxide is then reacted with 1-hexadecanol to 2-hexadecyl-l,3,2-dioxaphospholane-2-oxide. The 2-hexadecyl-l,3,2-dioxaphospholane-2-oxide is reacted with trimethylamine in the autoclave to hexadecylphosphocholine, the raw product is purified both with alkaline and with acid ion exchangers and recrystallized from acetone/chloroform. The analogous process is also used to prepare the octyl-, decyl-, dodecyl, tetradecyl and octadecyl derivatives.
The disadvantage of this process is that it is necessary to work with increased pressure in the last step of the process and that the use of trimethylamine constitutes an industrial hygiene problem in the technical preparation of the substance. It is also a disadvantage that the hydrolysis-sensitive intermediate products 2-chloro-l,3,2-dioxaphospholane, 2-chloro-l,3,2-dioxaphospholane-2-oxide and 2-hexadecyl-2-oxa10 1,3,2-dioxaphospholane need to be isolated and purified. In addition, environmentally-unfriendly solvents such as benzene are used, the solvents being changed from step to step.
All known processes use chromatographic methods for working up and purifying the raw products.
However, chromatographic working up processes of this kind have the following disadvantages: - their conversion to a technical scale causes difficulties since the dimensions of the stationary phase cannot be increased at will, - chromatographic processes are time-consuming.
The invention relates to a new, advantageous method of preparing and working up alkylphosphocholines.
It has surprisingly been found that the process of the invention achieves a higher total yield, despite the use of one less purification step than in previously known processes. In addition, the invention uses less solvent.
The process of the invention also avoids the use of alkylating reagents such as dimethyl sulphate which lead to a high potassium content of the product due to the use of potassium carbonate as an auxiliary base. The potassium content must be kept as low as possible in substances used as pharmaceutically active substances.
The process of the invention avoids the time-consuming chromatographic step during working up.
The product purity achieved in the process claimed is greater than in the known processes.
The first step in the conversion consists of the reaction of phosphorus oxychloride, optionally in the presence of halogenated hydrocarbons, saturated cyclic ethers, acyclic ethers, saturated hydrocarbons with 5 to 10 carbon atoms, liquid aromatic hydrocarbons which can also be substituted by halogen (in particular chlorine) or mixtures of the above mentioned solvents, and optionally in the presence of a basic substance conventionally used for this purpose, with an n-alkanol having a chain length of 14-18 hydrogen atoms.
Halogenated hydrocarbons that may for example be used are hydrocarbons of 1 to 6 carbon atoms, where one or several or all of the hydrogen atoms are replaced by chlorine atoms. It is for example possible to use methylene chloride, chloroform, ethylene chloride, chlorobenzene, dichlorobenzene. When halogen-substituted aromatic hydrocarbons are used, these are preferably substituted with 1 or 2 halogen atoms.
Saturated cyclic ethers that may be used are for example ethers with a ring size of 5-6 which consist of carbon atoms and 1 or 2 oxygen atoms.
Examples thereof are tetrahydrofuran and dioxan.
The acyclic ethers consist of 2 to 8 carbon atoms and are liquid. Examples that may be considered: diethylether, diisobutylether, methyl-tert.-butylether, diisopropyl ether.
Saturated hydrocarbons that may be considered are unbranched and branched hydrocarbons that consist of 5 to 10 carbon atoms and are liquid. Examples that may be considered are pentane, hexane, heptane, cyclohexane.
Aromatic hydrocarbons that may for example be considered are benzene and alkyl-substituted benzenes where the alkyl substituents consist of 1 to 5 carbon atoms.
Basic substances that may be considered both for the reaction of the phosphorus oxychloride with the n-alkanol and also for the subsequent reaction with the choline salt are amines, for example aliphatic amines of the formula NR1R2R3, where Rlr R2 and R3 are the same or different and represent hydrogen or Cj.-Cg-alkyl, aromatic amines such as pyridine, picoline, quinoline.
During the reaction with the choline salt it is possible to add the basic substance required herefor at the same time as the choline salt or before the choline salt. For the reaction with the choline salt a solvent is needed in any case; in other words, if the first reaction step is conducted without a particular solvent, one has to be added at this stage. The mol ratio of phosphorus oxychloride to the alkanol is for example between 1,5:1 to 1:1.1.
The choline salt is for example used in excess in relation to the alkanol (about 1.1 - 1.5 molar excess).
If the reaction of the phosphorus oxychloride with the alkanol occurs in the presence of a basic substance, the amount of the basic substance is for example 1 to 3 Mol related to 1 Mol POC13.
For the subsequent reaction with the choline salt the amount of basic substance used is for example 1 to 5 Mol related to 1 Mol alkanol.
The reaction temperature of the reaction of phosphorus oxychloride with n-alkanol lies between -30°C and +30°C, preferably -15°C and +5°C, in particular -10°C and -5°C.
The reaction time of this conversion is for example 0.5-5 hours, preferably 1-3 hours, in particular 1.5-2 hours. If the reaction occurs in the presence of a basic substance, it is generally quick (about 30 minutes).
The choline salt is then added in portions or in its entirety. Salts of choline that may for example be used are salts with mineral acids (such as sulphuric acid, hydrochloric acid), and also salts of choline with organic acids such as acetic acid, para-toluenesulphonic acid and the like.
This reaction step occurs in an inert solvent. Solvents that may be considered here are the same that are used to react the phosphorus oxychloride with the n-alkanol if this reaction occurs in a solvent.
The basic substance is then dissolved in one of the stated solvents or added dropwise without solvent.
The following are preferably used as solvent for the basic substance: halogenated hydrocarbons, saturated cyclic ethers, acyclic ethers, saturated hydrocarbons with 5 to 10 carbon atoms, liquid aromatic hydrocarbons or mixtures of the above mentioned solvents.
These are the same solvents that may be used for the reaction of phosphorus oxychloride with the n-alkanol.
Addition of the basic substance causes the temperature to rise. Care must be taken that the temperature is maintained within a range between 0°C to 40°C, preferably 10°C to 30°C, in particular at 15°C to 20°C.
The reaction mixture is then still stirred at 5°C to 30°C, preferably 15°C and 25°C (for example 1 hour to 40 hours, preferably 3 hours to 15 hours).
The hydrolysis of the reaction mixture occurs through addition of water, it being necessary to maintain a temperature between °C and 30°C, preferably 15°C and 30°C, in particular between °C and 20°C.
The previously mentioned hydrolysis liquids can also contain basic substances. Basic substances that may be considered include carbonates and hydrogen carbonates of the alkaline and alkaline earth metals.
To complete the hydrolysis the mixture is then stirred for a further 0.5 hours to 4 hours, preferably 1 to 3 hours, in particular 1.5 to 2.5 hours at 10°C to 30°C, preferably at 15°C to 25°C, in particular at 18°C to 22°C.
The reaction solution is then washed with a mixture of water and alcohols (preferably aliphatically saturated alcohols with 1 to 4 carbon atoms) which may optionally also contain a basic substance.
The mixing ratio water:alcohol may for example lie between 5 and 0.5, preferably 1-3 (V/V).
Basic substances that may be considered as washing liquid are for example carbonates and hydrogen carbonates of the alkaline and alkaline earth metals as well as ammonia in the form of the aqueous solution. A 3% sodium carbonate solution in water is particularly preferred.
It is then optionally possible to wash the reaction solution with an acid solution.
Acid washing is advantageous to remove not yet reacted basic portions of the reaction solution, in particular when methylene chloride is used as solvent.
The washing solution consists of a mixture of water and alcohols. Mixtures of aliphatically saturated alcohols with 1 to 4 carbon atoms are preferably used, an acid substance also optionally being present. The mixing ratio water:alcohol may for example lie between 5 and 0.5, preferably 1-3 (V/V).
Acid substances that may be considered for the washing liquid are for example mineral acids and organic acids, for example hydrochloric acid, sulphuric acid or tartaric acid, and citric acid.
A 10% solution of hydrochloric acid in water is particularly preferred.
The mixture is then washed one again with a mixture of water and alcohols. Mixtures of aliphatic saturated alcohols with 1 to 4 carbon atoms are preferably used, it also being possible for a basic substance to be optionally present.
The mixing ratio water: alcohol may for example lie between 5 and 0.5, preferably 1-3.
The washed phases are then combined and dried in conventional manner and the solvent is then removed (preferably under reduced pressure, for example 5-100 mbar) optionally after addition of 1.5-3 litres, preferably 2-2.5 litres of an aliphatic alcohol (related to 1 part by weight of dried product). Alcohols that may for example be used are saturated aliphatic alcohols with a chain length of 1 and 5 carbon atoms. The particularly preferred alcohol here is n-butanol, isopropanol. The purpose of this alcohol treatment is to remove the residual water completely.
The product so-obtained can be purified in the conventional manner (e.g. by chromatography, recrystallization).
An alkylphosphocholine raw product or the solid residue as described above is for example suspended in saturated aliphatic ketones (3-6 carbon atoms), for example acetone, butanone, methyl-tert.-butylketone, stirred for 1 to 4 hours, preferably 2 hours, suction filtered and dried at 20°C to 50°C in a vacuum at 5 Torr to 100 Torr.
The following purification process is, however, particularly preferred: The product prepurified in this manner is taken up in anhydrous alcohols (C-l to C4) or in alcohols which contain not more than up to 5 percent by weight of water at 20°C to 60°C, preferably 40°C and insoluble constituents filtered off.
Alcohols that may for example be used are methanol, ethanol, 5 isopropanol, butanol, isobutanol.
The prepurified product may also be dissolved in water.
The filtrate obtained is then stirred with a mixed-bed ion exchanger, for example AmberliteR MB3, for example for 1 to 5 hours, preferably 2 hours at 10°C to 50°C, preferably 20°C.
Instead of a mixed-bed ion exchanger the purification may also be effected simultaneously or successively with an acid ion exchanger and a basic ion exchanger.
Ion exchangers which may also be used are all insoluble solids which contain ion exchanging groups.
Acid ion exchangers are those which contain for example acid groups such as sulphonic acid groups, carboxyl groups. Examples are ion exchangers with sulphonic acid groups in a polystyrene matrix such as AmberliteR IR 120, DowexR HCR, DuoliteR C 20 or LewatitR S 100.
Weakly acid ion exchangers are for example those which carry carboxylic acid groups on the basis of a polyacrylic acid matrix, such as AmberliteR IRC 76, DuoliteR C 433 or ReliteR CC.
Basic ion exchangers that may for example be considered are those carrying on a polymer matrix (e.g. polystyrene matrix) primary, secondary, tertiary or quaternary amino groups such as DuoliteR A 101, DuoliteR A 102, DuoliteR15 A 348, DuoliteR A 365, DuoliteR A 375, AmberliteR IRA 67, DuoliteR A 375, AmberliteR IRA 458 and DuoliteR A 132.
Mixed-bed ion exchangers are mixtures of acid and alkaline ion exchanger resins, such as AmberliteR MB1, AmberliteR MB2, AmberliteR MB3 and AmberliteR MB6.
It is also possible to use all conventional ion exchangers in the process.
Reference is also made to Ullmann’s Encyclopedia of Industrial Chemistry, 5th Edition (1989), Volume A14, p. 450.
Following vacuum suctioning of the ion exchanger resin the mixture is evaporated under reduced pressure (for example 20 Torr to 200 Torr) at 40°C to 70°C and the mixture is then recrystallized from halogenated hydrocarbons or from alcohol/ketone mixtures.
Halogenated hydrocarbons that may for example be considered for the recrystallization are hydrocarbons containing 1 to 6 carbon atoms where one or several or all carbon atoms are replaced by chlorine atoms.
It is for example possible to use methylene chloride, chloroform, ethylene chloride, chlorobenzene.
Alcohols that may be considered are saturated aliphatic alcohols with 1 to 6 carbon atoms and 1 to 2 hydroxyl groups. Ketones that may be considered are saturated, aliphatic ketones with 3 to 8 carbon atoms.
The mixing ratio alcohol:ketone is 1 to 1-5 (volume/volume). An ethanol/acetone mixture in the ratio of 1:1 (V/V) is particularly preferred.
The crystals of alkylphosphocholine obtained are suction filtered and if necessary washed for example with saturated hydrocarbons containing 1 to 6 carbon atoms. (Temperature of the washing liquid for example 15 to 30°C).
Drying is effected for example in a vacuum at 40°C to 80°C over conventional drying agents, for example phosphorus pentoxide or silica gel.
Example 1 Preparation of hexadecyl phosphocholine 1.0 Mol (92 ml) POC13 in 1.5 1 chloroform are added to a 6-litre stirring apparatus under nitrogen and cooled in an ice bath to 5°C. 0.90 Mol (218 g) hexadecanol are dissolved in 700 ml chloroform and added dropwise together with 4.00 Mol (320 ml) pyridine at a temperature of 5 - 12°C. Dropping time: 1.25 hours. The dropping funnel is then flushed with the remaining 300 ml chloroform. After one and a half hours post-stirring at 0 - 5°C, 1.35 Mol (372 g) solid choline tosylate are added and then 400 ml pyridine added dropwise over 15 minutes. This causes the temperature to rise to 20°C. The ice bath is removed and the reaction mixture is stirred at room temperature for 3 hours. For purposes of hydrolysis 150 ml water are added dropwise over 20 minutes, the temperature rising from 25°C to 36°C. After stirring for half an hour, the reaction solution is washed in each case once with 1.50 litres water/methanol (1:1) , 1.50 litres 3% sodium carbonate/methanol (1:1) and 1.50 litres water/methanol (1:9). The chloroform phase washed in this manner is dried over sodium sulphate and evaporated in a rotary evaporator in a vacuum after addition of 50 ml i-propanol. n-butanol is added for drying and the mixture is evaporated in a rotary evaporator again.
Purification is carried out as follows: The residue is suspended in 2.0 litres acetone, stirred for approx. 2 hours, suction filtered and dried at 30°C in a vacuum. Raw yield: 325 g (87 %) . The raw product is taken up in 3.0 litres absolute ethanol and insoluble portions filtered off. The filtrate is stirred for two hours with 1.0 litres mixed-bed ion exchanger Amberlite MB 3R(FLUKA). After suction filtration of the ion exchanger resin the mixture is evaporated in a rotary evaporator in a vacuum and then recrystallized once from 0.70 litres methylene chloride. Complete crystallization is achieved in the refrigerator. The crystals are suction filtered and washed with pentane. The mixture is then dried in a vacuum at 30°C over phosphorus pentoxide.
Yield 193 g (0.47 Mol, 53 %) The reaction product has a melting point of 241 - 245°C.
Examples 2-5 are prepared according to the same procedure.
Example 2: II ® D-19 3 9 0 : H3C- (CH2) 13-0-P-0- (CH2) 2-N (CH3) 3 i® Mp: 260°C (disintegration) C19H42NO4P (379.52) TL: 89 a (chloroform/methanol/ammonia 25% =70:20:10) Rf :0.27 EA: calc. C 60.13% H 11.16% N 3.69% *h2o 57.41% 11.16% 3.52% found C 57.40% H 11.42 N 3.61% 57.43% 11.47% 3.65% •H-NMR: (250 MHz, CDC13) <5 = 0. 90 ppm (t,3H) 3.80 1.25 (m,22H) 3.85 (m,2H) 1.55 (p,2H) 4.25 (m,2H) 3.40 (s,9H) Example 3: D-20403 : H3C-(CH2)14-O-P-O-(CH2)2-N(CH3)3 £ Mp: 244°C (disintegration) C20H44NO4P (393.55) TL: 89 a (chloroform/methanol/ammonia 25% =70:40:10) Rf :0.49 EA: calc. *2H2O found C 61.04% H 11.27% 11.26% H 10.99 10.85% N 3.56% 3.26% N 3.67 3.59% C 55.92% 56.14% 55.74% 'H-NMR: (250 MHz, cdci3) δ = 0.90 ppm (t,3H) 3.80 (q,2H) 1.30 (m,24H) 3.85 (m,2H) 1.55 (p,2H) 4.25 (m,2H) 3.40 (s,9H) Example 4: O II Φ D-19767: H3C-(CH2) 16-O-P-O-(CH2) 2-N(CH3) 3 is Mp: 254 - 256°C C22H48NO4P (421.61) TL: 127 c (I-butanol/glacial acetic acid/water=60:20:20) Rf:0.34 EA: calc. *H2° found C 62.68% 60.11% C 60.2% H 11.48% 11.46% H 11.7 N 3.32% 3.19% N 3.1% 60.5% Ή-NMR: (250 MHz, CDC13) δ = 0.90 ppm (t,3H) 3.8 1.25 (m,28H) 3.85 (m,2H) 1.60 (p,2H) 4.25 (m,2H) 3.40 (S,9H) 11.7% Jr (q,2H) Example 5: O II D-19391: H3C-(CH2) 17-O-P-O- (CH2) 2-N(CH3) 3 0» Mp: 258°C (disintegration) C23H50NO4P (435.62) TL: 126 (I-butanol/glacial acetic acid/water=40:10:10) Rf:0.13 EA: calc. *h2o found C 63.41% H 11.57% 11.55% H 11.93 12.02% N 3.22% 3.09% N 3.15% 3.15% C 60.90% 60.80% 60.83% 'H-NMR: (250 MHz, CDC13) δ = 0.90 ppm (t,3H) 3.80 (q,2H) 1.25 (m,30H) 3.85 (m,2H) 1.60 (p,2H) 3.40 (s,9H) 4.30 (m,2H)
Claims (5)
1. Process for the production of C 14 -C ia alkylphosphocholines by reacting an n-alkanol with phosphorus oxychloride and a choline salt, characterised in that, in a single-vessel process, an n-alkanol having a chain length of C 14 -C 18 is reacted with phosphorus oxychloride in an inert solvent or also without a solvent in the presence or absence of a basic substance, the resultant product is further reacted, without isolation and purification, with a choline salt in an inert solvent in the presence of a basic substance to yield the phosphoric acid diester chloride and the alkylphosphocholine is liberated and isolated by subsequent hydrolysis.
2. Process for the production of C 14 -C ia alkylphosphocholines according to claim I, characterised in that a solution of the alkylphosphocholines obtained using the process according to claim 1 is treated in ah organic medium with a mixed bed ion exchanger or in succession with an acidic ion exchanger and a basic ion exchanger.
3. . Process for the production of C 14 -C 18 alkylphosphocholines according to claim 1, characterised in that the temperature during the reaction of the crude product with the choline salt/base is between 0°C and 40°C.
4. A process according to Claim 1 for the preparation of a C., .-C., o -alkylphosphocholine, substantially as I 4 1 O hereinbefore described and exemplified.
5. A C,C. o -alkylphosphocholine, whenever prepared by a 14 Io process claimed in a preceding claim.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4122127 | 1991-07-04 |
Publications (2)
Publication Number | Publication Date |
---|---|
IE922182A1 IE922182A1 (en) | 1993-01-13 |
IE80555B1 true IE80555B1 (en) | 1998-09-23 |
Family
ID=6435410
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE922182A IE80555B1 (en) | 1991-07-04 | 1992-07-03 | A process for the preparation of alkylphosphocholines and the production thereof in pure form |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0521297B1 (en) |
JP (1) | JP3171279B2 (en) |
CN (1) | CN1034941C (en) |
AT (1) | ATE158295T1 (en) |
AU (2) | AU652646B2 (en) |
CA (1) | CA2073126C (en) |
DE (2) | DE59208905D1 (en) |
DK (1) | DK0521297T3 (en) |
EG (1) | EG20551A (en) |
ES (1) | ES2108715T3 (en) |
FI (1) | FI107260B (en) |
GR (1) | GR3025490T3 (en) |
HU (1) | HU219243B (en) |
IE (1) | IE80555B1 (en) |
IL (1) | IL102379A (en) |
NO (2) | NO304232B1 (en) |
PL (1) | PL169571B1 (en) |
SG (1) | SG47844A1 (en) |
ZA (1) | ZA924980B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE59205998D1 (en) * | 1991-07-04 | 1996-05-23 | Asta Medica Ag | Medicament with antineoplastic activity containing octadecyl- [2- (N-methylpiperidino) ethyl] phosphate as active ingredient and process for its preparation |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3164332D1 (en) * | 1980-10-21 | 1984-07-26 | Boehringer Mannheim Gmbh | Phospholipids that contain sulphur, process for their preparation and medicines containing these compounds |
JPS60184092A (en) * | 1984-03-01 | 1985-09-19 | Kao Corp | Phosphoric ester and its preparation |
CA1338627C (en) * | 1985-12-04 | 1996-10-01 | Hansjorg Eibl | Pharmaceuticals based on phosphoric acid esters for use in tumor therapy, and process for their preparation |
EP0336142A3 (en) * | 1988-04-04 | 1991-04-24 | American Cyanamid Company | Novel antagonists of platelet activating factor |
IT1229238B (en) * | 1989-05-08 | 1991-07-26 | Istituto Chemioterapico | PROCEDURE FOR THE PREPARATION OF L-ALPHA-GLYCERYLPHOSPHORYLCHOLINE AND ALPHA-GLYCERYLPHOSPHORYLETHANOLAMINE. |
-
1992
- 1992-05-26 AT AT92108826T patent/ATE158295T1/en active
- 1992-05-26 EP EP92108826A patent/EP0521297B1/en not_active Expired - Lifetime
- 1992-05-26 SG SG1996004669A patent/SG47844A1/en unknown
- 1992-05-26 DK DK92108826.6T patent/DK0521297T3/en active
- 1992-05-26 DE DE59208905T patent/DE59208905D1/en not_active Expired - Lifetime
- 1992-05-26 ES ES92108826T patent/ES2108715T3/en not_active Expired - Lifetime
- 1992-06-25 DE DE4220852A patent/DE4220852C2/en not_active Expired - Lifetime
- 1992-07-01 EG EG34492A patent/EG20551A/en active
- 1992-07-02 PL PL92295129A patent/PL169571B1/en unknown
- 1992-07-02 IL IL10237992A patent/IL102379A/en not_active IP Right Cessation
- 1992-07-02 NO NO922612A patent/NO304232B1/en not_active IP Right Cessation
- 1992-07-03 AU AU19441/92A patent/AU652646B2/en not_active Expired
- 1992-07-03 IE IE922182A patent/IE80555B1/en not_active IP Right Cessation
- 1992-07-03 ZA ZA924980A patent/ZA924980B/en unknown
- 1992-07-03 JP JP17691392A patent/JP3171279B2/en not_active Expired - Lifetime
- 1992-07-03 HU HU9202233A patent/HU219243B/en unknown
- 1992-07-03 CN CN92105432A patent/CN1034941C/en not_active Expired - Lifetime
- 1992-07-03 FI FI923087A patent/FI107260B/en not_active IP Right Cessation
- 1992-07-03 CA CA002073126A patent/CA2073126C/en not_active Expired - Lifetime
-
1994
- 1994-06-29 AU AU66059/94A patent/AU663259B2/en not_active Expired
-
1997
- 1997-11-26 GR GR970403139T patent/GR3025490T3/en unknown
-
1998
- 1998-04-17 NO NO981742A patent/NO304316B1/en not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6028209A (en) | Process for the preparation of alkylphosphocholines and the production thereof in pure form | |
CA2073126C (en) | Preparation of alkylphosphocholines | |
JP3115489B2 (en) | Method for producing phosphate monoester | |
EP1981896B1 (en) | An improved process for the preparation of risedronate sodium hemi-pentahydrate | |
EP1370565B1 (en) | Method of producing 1-hydroxy-1,1-diphosphonic acid compounds | |
EP0521353B1 (en) | Antineoplastic medicament containing octadecyl-[2-(N-methylpiperidino)-ethyl] phosphate and synthesis thereof | |
US4774350A (en) | Phosphoric ester | |
JP3688304B2 (en) | Phospholipid derivative, method for producing the derivative, purification method for the derivative, pharmaceutical product containing the derivative, and method for producing the pharmaceutical product | |
US4740609A (en) | Phosphoric esters and process for preparing same | |
EP1619190B1 (en) | Salts of (2s,3s)-3- [[(1s)-1-isobutoxymethyl-3-methylbutyl]carbamoyl] oxirane-2-carboxylic acid | |
US2361286A (en) | Phosphoric acid esters of glycerol ethers and their manufacture | |
JP2649343B2 (en) | Method for producing phosphate ester | |
US5958906A (en) | Phospholipid derivatives containing higher elements of the fifth main group | |
US4279838A (en) | Process for the preparation of aminoaryl thiophosphates and aminoaryl phosphates | |
JPH04282390A (en) | Production of phosphoric diester | |
JPS62258392A (en) | Ammonium monofluorophosphate and its production | |
JPS6248689A (en) | Production of phosphoric acid ester |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK9A | Patent expired |